Power Law company profile

Wave Life Sciences

Biotech & Life Sciences · Cambridge, United States · Founded 2012 · IPO 2015 Unicorn

WaVe Life Sciences is leading the development of next-generation nucleic acids for therapeutic and diagnostic applications

Valuation

$827M

Market cap · May/2026

Revenue

$43M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

6 investors on Wave Life Sciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage

RA Capital Management

Series B+ 5 investors entered at this stage

Jennison Associates

Redmile Group

New Leaf Venture Partners

Foresite Capital

Cormorant Asset Management

Global footprint

Where Wave Life Sciences has talent and traffic

AI talent share

0.8% of workforce is AI talent
(3 of 371 staff)

Core AI00%

Other AI30.81%

Non-AI workforce36899.19%

Workforce by country

7 countries with
team presence

🇺🇸 United States93.3%

🇬🇧 United Kingdom4.8%

🇯🇵 Japan1.1%

🇯🇴 Jordan0.4%

🇲🇽 Mexico0.4%

Top 5 of 7 shown

Web traffic by country

23K monthly visits
across markets

🇺🇸 United States60.9%

🇬🇧 United Kingdom14.8%

🇮🇳 India7.8%

🇯🇵 Japan3.5%

🇨🇦 Canada3%

Top 5 markets shown

Market sentiment

What the market is saying about Wave Life Sciences

An AI-synthesized read of the highest-engagement posts about Wave Life Sciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Wave Life Sciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles